Last week, Moderna Inc (NASDAQ: MRNA) said it asked the FDA to authorize the use of its updated booster shot in children ages 6 to 17. The company expects to complete a request for the use of the booster in children six months through 5 years later this year.
Pfizer Resumes Dosing In Phase 3 Hemophilia Gene Therapy Trial Six Months After FDA Lifts Clinical Hold
September 23, 12:02 PM
Pfizer Inc (NASDAQ:PFE) and its partner Sangamo Therapeutics Inc (NASDAQ:SGMO) have reopened enrollment in phase 3 AFFINE study hemophilia A gene therapy trial. …
September 22, 1:42 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
September 20, 2:45 PM
RBC Capital Markets raised the price target on Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) from $225 to $250. The analyst says that the company…
September 20, 11:08 AM
September 20, 10:09 AM
September 20, 4:46 AM
Haleon has notified GSK and Pfizer that it rejects their requests for indemnification on the basis that the scope of the indemnities set out in the joint venture agreement only covers their consumer healthcare businesses as conducted when the JV was formed in 2018. At that time, neither GSK nor Pfizer marketed OTC Zantac in the US or Canada.